Abstract
For sustained growth, tumors are dependent upon neovascularization to feed their massive demand for nutrients and oxygen. Cancer cells produce growth factors and activators that stimulate vessels in the surrounding tissue to form a new circulatory network around the tumor. Therapies aimed at reducing the blood flow to the cancer cells can slow down tumor growth and reduce metastasis. This review describes novel anti-angiogenic agents, including antibodies directed against vascular growth factors and angiotensin II, pharmaceutical compounds and natural metabolites derived from plants and microorganisms. The relevant patents are discussed. These agents may become valuable anti-cancer therapeutics in the future, as a supplement to chemo- and radiation-therapy.
Keywords: Angiogenesis, antibiotics, antibody therapy, angiotensin-converting enzyme inhibitors, angiotensin II receptor 1 antagonists, combination therapy, matrix metalloproteinases, opioids, polyphenols, simmondsins
Recent Patents on Anti-Cancer Drug Discovery
Title: Anti-Angiogenic Agents and Cancer: Current Insights and Future Perspectives
Volume: 4 Issue: 2
Author(s): Boel De Paepe
Affiliation:
Keywords: Angiogenesis, antibiotics, antibody therapy, angiotensin-converting enzyme inhibitors, angiotensin II receptor 1 antagonists, combination therapy, matrix metalloproteinases, opioids, polyphenols, simmondsins
Abstract: For sustained growth, tumors are dependent upon neovascularization to feed their massive demand for nutrients and oxygen. Cancer cells produce growth factors and activators that stimulate vessels in the surrounding tissue to form a new circulatory network around the tumor. Therapies aimed at reducing the blood flow to the cancer cells can slow down tumor growth and reduce metastasis. This review describes novel anti-angiogenic agents, including antibodies directed against vascular growth factors and angiotensin II, pharmaceutical compounds and natural metabolites derived from plants and microorganisms. The relevant patents are discussed. These agents may become valuable anti-cancer therapeutics in the future, as a supplement to chemo- and radiation-therapy.
Export Options
About this article
Cite this article as:
De Paepe Boel, Anti-Angiogenic Agents and Cancer: Current Insights and Future Perspectives, Recent Patents on Anti-Cancer Drug Discovery 2009; 4 (2) . https://dx.doi.org/10.2174/157489209788452821
DOI https://dx.doi.org/10.2174/157489209788452821 |
Print ISSN 1574-8928 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3970 |
Call for Papers in Thematic Issues
Novel anti-cancer drugs in photoimmunotherapy management: from bench to translational research
In recent years, traditional cancer treatments, such as surgery, chemotherapy, and radiation treatment, etc., may damage the pathological tissue and normal cells. The ideal tumor treatment should be noninvasive, eliminating the primary tumor, making the body produce systemic tumor-specific immunity, eliminating metastases, and having less /no side effects. Recent Patents ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MDMA Administration and Heat Shock Proteins Response: Foreseeing a Molecular Link
Current Pharmaceutical Biotechnology The Role of MIF in Hepatic Function, Oxidative Stress, and Inflammation in Thioacetamide-induced Liver Injury in Mice: Protective Effects of Betaine
Current Medicinal Chemistry Solvent-Free and Self-Catalyzed Three-Component Synthesis of Diversely Substituted Pyrazolo[1,4]thiazepinones of Potential Antitumor Activity
Current Organic Synthesis Design, Preparation and Characterization of Modular Squalene-based Nanosystems for Controlled Drug Release
Current Topics in Medicinal Chemistry IT-143, A Polymer Micelle Nanoparticle, Widens Therapeutic Window of Daunorubicin
Pharmaceutical Nanotechnology Piperidin-4-one: The Potential Pharmacophore
Mini-Reviews in Medicinal Chemistry Omega-3 and Renal Function in Older Adults
Current Pharmaceutical Design Review of Clinical Equipoise: Examples from Oncology Trials
Current Reviews in Clinical and Experimental Pharmacology Pernicious Anemia: Fundamental and Practical Aspects in Diagnosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Antisense Technologies Targeting Fatty Acid Synthetic Enzymes
Recent Patents on Anti-Cancer Drug Discovery Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma
Current Medicinal Chemistry A Review on Chemical Profile of Coumarins and their Therapeutic Role in the Treatment of Cancer
Current Drug Delivery Extracellular Targeting of Synthetic Therapeutic Nucleic Acid Formulations
Current Gene Therapy Carbohydrates: Potential Sweet Tools Against Cancer
Current Medicinal Chemistry HLA-G - From Fetal Tolerance to a Regulatory Molecule in Inflammatory Diseases
Current Immunology Reviews (Discontinued) Antibacterial Combination of Oleoresin from Copaifera multijuga Hayne and Biogenic Silver Nanoparticles Towards Streptococcus agalactiae
Current Pharmaceutical Biotechnology Electro-Acupuncture Protects Diabetic Nephropathy-Induced Inflammation Through Suppression of NLRP3 Inflammasome in Renal Macrophage Isolation
Endocrine, Metabolic & Immune Disorders - Drug Targets Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells
Recent Patents on Anti-Cancer Drug Discovery TAP-Independent MHC Class I Presentation
Current Immunology Reviews (Discontinued) Macrocyclic Inhibitors of Hsp90
Current Topics in Medicinal Chemistry